InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Zordani Richard A. Jr., Director. Officer active across 1 companies, notably Galectin Therapeutics INC. In total, 3 disclosures have been logged. Total volume traded: €25k. The latest transaction was disclosed on 4 April 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations3 total
€7,3115,000 shares@ €1.46230.0051% mcap29.3% of flow
Common Stock
SEC:0001133416-22-000053:0·
Ideal exit: 30 Dec 2022 (T+270)
€8,8155,000 shares@ €1.7631100.0% of flow
Common Stock
SEC:0001133416-22-000006·
Ideal exit: 11 Oct 2022 (T+270)
€8,8155,000 shares@ €1.76310.0062% mcap35.3% of flow
Common Stock
SEC:0001133416-22-000006:0·
Ideal exit: 11 Oct 2022 (T+270)
3 of 3 declarations
About Zordani Richard A. Jr.
Richard A. Zordani Jr. is a Director at GALECTIN THERAPEUTICS INC. In this role, he participates in the governance of the company and strategic decision-making. His experience in the biopharmaceutical sector is valuable in guiding the firm's research and development initiatives.
